Jeffrey Tate Cyclo Therapeutics, Inc. (CYTH) insider trading activity

Jeffrey Tate is Chief Operating Officer of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 92,042 shares of CYTH, which is worth approximately $69,951. The most recent transaction as insider was on Oct 20, 2023, when has been sold 29,941 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $21,258. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K

0% 3M change

0% 12M change

Total Value Held $69,951

JEFFREY TATE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 20 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	$21,258 $0.71 p/Share	29,941 Added 24.55%	92,042 Common Stock
Apr 20 2023	BUY Open market or private purchase	$21,258 $0.71 p/Share	29,941 Added 32.53%	62,101 Common Stock
May 16 2022	BUY Open market or private purchase	$6,360 $2.12 p/Share	3,000 Added 8.53%	32,160 Common Stock
Apr 29 2022	BUY Open market or private purchase	$3,699 $2.71 p/Share	1,365 Added 4.47%	29,160 Common Stock
Apr 28 2022	BUY Open market or private purchase	$1,588 $2.5 p/Share	635 Added 2.23%	27,795 Common Stock
Mar 29 2021	BUY Open market or private purchase	$15,000 $7.5 p/Share	2,000 Added 6.86%	27,160 Common Stock
Jan 13 2021	BUY Grant, award, or other acquisition	-	10,000 Added 28.44%	25,160 Common Stock
Dec 11 2020	BUY Grant, award, or other acquisition	-	5,000 Added 24.8%	15,160 Common Stock

Jeffrey Tate

Chief Operating Officer

Gainesville, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Value

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH

Account